Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-05

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for levocetirizine dihydrochloride, a generic antihistamine used for allergy symp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)